Class and drugs Flashcards

1
Q

Beta-Blocker

beta-adrenergic blocker

A

-olol (metoprolol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alpha-2 Adrenergic Agonist

stimulates alpha-2 adrenergic = reduced sympathetic outflow = decrease in peripheral resistance, renal vascular resistance, heart rate, and blood pressure

A

Clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vasodilator

direct VASODILATION OF ARTERIES = lowered blood pressure

A

Hydralazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Venodilator

forms nitric oxide = activate guanylate cyclase = increase cGMP = VASODILATION ON VEINS

A

Nitroglycerin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antianginal

reduces intracellular sodium concentration = reduces calcium influx = reduces ventricular tension and myocardial oxygen consumption

A

Ranolazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ARB/Neprilysin inhibitor

Angiotensin II blocker = vasodilation
Inhibits neprilysin –> decrease breakdown of peptides = vasodilation

A

Sacubitril/Valsartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cardiac Glycoside

Atrial fibrillation: suppression of AV node conduction = increase refractory period and decrease conduction velocity

Heart failure: inhibition of sodium/potassium ATPase pump = increase of intracellular sodium which promotes calcium influx = increased contraction force

A

Digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Class III Antiarrythmic

inhibits adrenergic stimulation and prolongs the action potential and refractory period

A

Amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

P2Y12 Inhibitor

irreversibly and directly blocks ADP from binding

A

Clopidogrel, Prasugrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

P2Y12 Inhibitor

reversible and allosterically changes ADP receptor so ADP can’t bind

A

Ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Platelet Aggregation Inhibitor

inhibits uptake of adenosine = inhibits platelet aggregation; irreversible inhibition of platelet cyclooxygenase = inhibits (TXA2) formation

A

Dipyridamole/Acetylsalicylic Acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Factor XA-Inhibitor

inhibition of factor Xa = decrease conversion of prothrombin to thrombin

A

-XABAN (Apixaban, Rivaroxaban)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Direct Thrombin Inhibitor

competitive, reversible, direct thrombin inhibitor = blocks thrombin from converting fibrinogen into fibrin

A

Dabigatron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Low Molecular Weight Heparin

makes antithrombin stronger = decreased conversion of prothrombin to thrombin

A

Enoxaparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vitamin K Antagonist

Prevents conversion of vitamin K to active form = impairs formation of clotting factors II, VII, IX, X and protein C & S (body’s natural coagulants)

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dipeptidyl Peptidase (DPP-4) Inhibitor

blocks DPP-4 from inactivating GLP-1 = stimulates insulin secretion/suppresses glucagon secretion

A

-GLIPTIN (Sitagliptin, Saxagliptin, Linagliptin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sulfonylureas

increases insulin secretion from pancreatic B-cells

A

Glipizide, Glimepiride

18
Q

Biguanide

decreases blood glucose (liver – decrease glucose production, intestine – increase glucose metabolism/decrease glucose absorption, muscle – increases conversion of glucose to glucagon)

19
Q

Thiazolidinedione (TZD)

increases glucose uptake in muscles

A

Pioglitazone

20
Q

Meglitinide

stimulates insulin release from pancreas

A

Repaglinide

21
Q

Glucagon-like peptide-I (GLP-I) receptor agonists

increases insulin release and decreases hepatic glucose output, gastric emptying, suppresses appetite

A

-GLUTIDE (Dulaglutide, Exenatide, Liraglutide, Semaglutide)

22
Q

Sodium-Glucose-CoTransport 2 (SGLT2) inhibitor

inhibits SGLT2 in the proximal renal tubules = reduced absorption of glucose from tubular lumen

A

-GLIFLOZIN (Dapagliflozin, Canagliflozin, Empagliflozin)

23
Q

Insulin

A

Insulin Degludec, Insulin glargine

24
Q

Bisphosphonates

inhibits osteoclast activity = decrease in bone breakdown & increases bone mineral density

A

Alendronate

25
Q

Selective estrogen receptor modulators (SERMs)

increase estrogen = decrease bone reabsorption/turnover & increases bone mineral density

A

Raloxifene

26
Q

Synthetic Thyroxine T4

converted to T3 = activation or repression of specific genes

A

Levothyroxine

27
Q

Desiccated Thyroid

naturally derived thyroid replacement contains T4 and T3

A

Armour Thyroid

28
Q

Antithyroid Agent

inhibits release of thyroid hormones = inhibits synthesis of thyroid hormones

A

Potassium Iodide

29
Q

Proton Pump Inhibitors (PPI)

irreversibly blocking the hydrogen/potassium ATPase (gastric proton pump)

A

-PRAZOLE (Omeprazole, Pantoprazole)

30
Q

Histamine Type 2 Receptor Antagonists (H2RA)

blocks histamine at H2 receptor on parietal cell

A

Famotidine

31
Q

Mucosal Protectant

forms a viscous paste adhesive that acts locally to protect gastric lining

A

Sucralfate

32
Q

Antiemetics

Phenothiazine class – inhibits dopamine, histamine, and muscarinic (parasympathetic) activity

A

Promethazine, Prochlorperazine

33
Q

Antiemetic

inhibits dopamine = enhances response to acetylcholine in upper GI tract and blocks signals to trigger vomiting

A

Metoclopramide

34
Q

Antiemetic

5-HT3 receptor antagonist = block serotonin

A

Ondansetron

35
Q

Anti-Diarrheal

works on mu and delta receptors in the gut/reduce abuse potential

A

Diphenoxylate/atropine

36
Q

Irritable Bowel Syndrome (IBS)

anticholinergic – blocks acetylcholine at muscarinic receptors in smooth muscles

A

Dicyclomine

37
Q

Irritable Bowel Syndrome (IBS)

increases cGMP = increase Cl secretion = increase intestinal fluid & GI transit is accelerated

A

Linaclotide

38
Q

Irritable Bowel Syndrome (IBS)

Cl channel activator = increases intestinal fluid & increases poop transit

A

Lubiprostone

39
Q

Irritable Bowel Syndrome (IBS)

Inhibits bacterial RNA synthesis by binding to bacterial DNA-dependent RNA polymerases

40
Q

Constipation

osmotic agent = pulls water into stool

A

Polyethylene glycol